| Prev Close | 18.82 |
| Day Low/High | 18.22 / 18.82 |
| 52 Wk Low/High | 13.81 / 27.99 |
| Avg Volume | 44.50K |
| Exchange | NASDAQ |
| Shares Outstanding | 5.49M |
| Market Cap | 103.35M |
| EPS | 1.20 |
| P/E Ratio | 13.74 |
| Div & Yield | 0.60 (3.20%) |
Looking at the universe of stocks we cover at Dividend Channel, on 8/10/17, Psychemedics Corp. will trade ex-dividend, for its quarterly dividend of $0.15, payable on 8/24/17.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Looking at the universe of stocks we cover at Dividend Channel, on 5/4/17, Psychemedics Corp. will trade ex-dividend, for its quarterly dividend of $0.15, payable on 5/18/17.
Sets Lead Plaintiff Deadline of April 3, 2017 -- PMD
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Psychemedics Corporation ("Psychemedics") (NASDAQ: PMD) between...
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of...
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Psychemedics Corporation (NASDAQ: PMD) securities...
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Psychemedics Corporation (NASDAQ: PMD) securities...
Psychemedics and Span-America show promise for long-term growth.
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of...
Glancy Prongay & Murray LLP ("GPM")Â announces that a class action lawsuit has been filed on behalf of investors who purchased Psychemedics Corporation ("Psychemedics" or the "Company") (NASDAQ: PMD)...
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Psychemedics Corporation securities (NASDAQ:PMD) from February 28, 2014 through January 30, 2017, inclusive (the "Class Period") of the important...
Looking at the universe of stocks we cover at Dividend Channel, on 2/14/17, Psychemedics Corp. will trade ex-dividend, for its quarterly dividend of $0.15, payable on 2/27/17.
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Psychemedics Corporation ("Psychemedics") (NASDAQ:PMD) between...
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Psychemedics Corporation securities (NASDAQ: PMD) from February 28, 2014 through January 30, 2017,...
Holzer & Holzer, LLC announces that a class action lawsuit has been filed on behalf of investors who purchased Pyschemedics Corporation ("Pyschemedics" or the "Company") (NASDAQ: PMD) securities between February 28,...
Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Psychemedics Corporation ("Psychemedics" or the "Company") (Nasdaq: PMD) concerning possible violations of federal...
Levi & Korsinsky announces it has commenced an investigation of Psychemedics Corporation (NASDAQ:PMD) concerning possible violations of federal securities laws.
Holzer & Holzer, LLC is investigating whether certain statements issued by Psychemedics Corporation ("Psychemedics" or the "Company") (NASDAQ: PMD) complied with federal securities laws.
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Psychemedics Corporation (NASDAQ: PMD) resulting from allegations that Psychemedics...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Looking at the universe of stocks we cover at Dividend Channel, on 11/3/16, Psychemedics Corp. will trade ex-dividend, for its quarterly dividend of $0.15, payable on 11/17/16.
Looking at the universe of stocks we cover at Dividend Channel, on 8/3/16, Psychemedics Corp. will trade ex-dividend, for its quarterly dividend of $0.15, payable on 8/15/16.
Looking at the universe of stocks we cover at Dividend Channel, on 5/4/16, Psychemedics Corp. will trade ex-dividend, for its quarterly dividend of $0.15, payable on 5/18/16.
